SE408179B - Analogiforfarande for framstellning av imidazo(5,1-a)-as-triaziner - Google Patents
Analogiforfarande for framstellning av imidazo(5,1-a)-as-triazinerInfo
- Publication number
- SE408179B SE408179B SE7400062A SE7400062A SE408179B SE 408179 B SE408179 B SE 408179B SE 7400062 A SE7400062 A SE 7400062A SE 7400062 A SE7400062 A SE 7400062A SE 408179 B SE408179 B SE 408179B
- Authority
- SE
- Sweden
- Prior art keywords
- triazines
- imidazo
- preparation
- analogical procedure
- analogical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB55373*[A GB1457873A (en) | 1973-01-04 | 1973-01-04 | Imidazotriazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE408179B true SE408179B (sv) | 1979-05-21 |
Family
ID=9706420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7400062A SE408179B (sv) | 1973-01-04 | 1974-01-03 | Analogiforfarande for framstellning av imidazo(5,1-a)-as-triaziner |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US3941785A (cg-RX-API-DMAC7.html) |
| JP (1) | JPS4995994A (cg-RX-API-DMAC7.html) |
| AT (1) | AT336029B (cg-RX-API-DMAC7.html) |
| AU (1) | AU474078B2 (cg-RX-API-DMAC7.html) |
| BE (1) | BE809369A (cg-RX-API-DMAC7.html) |
| CA (1) | CA1005057A (cg-RX-API-DMAC7.html) |
| CH (1) | CH618170A5 (cg-RX-API-DMAC7.html) |
| DE (1) | DE2364076A1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES422001A1 (cg-RX-API-DMAC7.html) |
| FI (2) | FI57260C (cg-RX-API-DMAC7.html) |
| FR (1) | FR2213058B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1457873A (cg-RX-API-DMAC7.html) |
| IE (1) | IE38681B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL43872A (cg-RX-API-DMAC7.html) |
| LU (1) | LU69099A1 (cg-RX-API-DMAC7.html) |
| NL (1) | NL7400095A (cg-RX-API-DMAC7.html) |
| NO (1) | NO140301C (cg-RX-API-DMAC7.html) |
| SE (1) | SE408179B (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA739534B (cg-RX-API-DMAC7.html) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK109578A (da) * | 1977-03-25 | 1978-09-26 | Allen & Hanburys Ltd | Fremgangsmaade til fremstilling af heterocycliske forbindelser |
| US4096257A (en) * | 1977-05-23 | 1978-06-20 | American Cyanamid Company | Substituted imidazo [1,2-d]-as-triazines |
| US4107309A (en) * | 1977-05-23 | 1978-08-15 | American Cyanamid Company | Substituted imidazo[1,2-d]-as-triazines |
| US4126444A (en) * | 1977-11-22 | 1978-11-21 | American Cynamid Company | Substituted imidazo (1,5-D)-as-triazin-4-ols, and herbicidal use thereof |
| US4308384A (en) * | 1978-09-18 | 1981-12-29 | Glaxo Group Limited | Production of triazinones |
| DD244681A3 (de) * | 1985-12-02 | 1987-04-15 | Zeiss Jena Veb Carl | Vorrichtung zur positionierung von enden flexibler lichtleitelemente |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| HU230154B1 (hu) | 1997-11-12 | 2015-09-28 | Bayer Intellectual Property Gmbh | Eljárás 2-es helyzetben fenil-szubszituenst hordozó imidazo-triazinon-származékok előállítására |
| DE19827640A1 (de) * | 1998-06-20 | 1999-12-23 | Bayer Ag | 7-Alkyl- und Cycloalkyl-substituierte Imidazotriazinone |
| BR9913152A (pt) | 1998-08-26 | 2001-05-15 | Smithkline Beecham Corp | Terapias para tratamento de doenças pulmonares |
| EP1671651B1 (en) * | 1999-08-21 | 2009-11-11 | Nycomed GmbH | Synergistic combination of pumafentrine and salmeterol |
| CN1633298A (zh) * | 2001-05-09 | 2005-06-29 | 拜尔健康护理股份公司 | 2－苯基取代的咪唑三嗪酮的新用途 |
| GB0113343D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel Heterocycles 2 |
| GB0113344D0 (en) * | 2001-06-01 | 2001-07-25 | Bayer Ag | Novel heterocycles 3 |
| DE10130167A1 (de) * | 2001-06-22 | 2003-01-02 | Bayer Ag | Imidazotriazine |
| DE10135815A1 (de) | 2001-07-23 | 2003-02-06 | Bayer Ag | Verwendung von 2-Alkoxyphenyl-substituierten Imidazotriazinonen |
| DE10230605A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Substituierte Imidazotriazine |
| DE10230604A1 (de) * | 2002-07-08 | 2004-01-29 | Bayer Ag | Heterocyclisch substituierte Imidazotriazine |
| DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
| WO2004087652A2 (en) * | 2003-04-01 | 2004-10-14 | Smithkline Beecham Corporation | Imidazotriazine compounds |
| DE102005001989A1 (de) * | 2005-01-15 | 2006-07-20 | Bayer Healthcare Ag | Intravenöse Formulierungen von PDE-Inhibitoren |
| DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
| DE102005009241A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit kontrollierter Bioverfügbarkeit |
| EP2258358A3 (en) | 2005-08-26 | 2011-09-07 | Braincells, Inc. | Neurogenesis with acetylcholinesterase inhibitor |
| EP2275096A3 (en) | 2005-08-26 | 2011-07-13 | Braincells, Inc. | Neurogenesis via modulation of the muscarinic receptors |
| BRPI0616633A2 (pt) * | 2005-09-29 | 2011-06-28 | Bayer Healthcare Ag | inibidores de pde e combinações dos mesmos para o tratamento de transtornos urológicos |
| AU2006304787A1 (en) | 2005-10-21 | 2007-04-26 | Braincells, Inc. | Modulation of neurogenesis by PDE inhibition |
| CA2625210A1 (en) | 2005-10-31 | 2007-05-10 | Braincells, Inc. | Gaba receptor mediated modulation of neurogenesis |
| CA2643199A1 (en) * | 2006-03-08 | 2007-09-13 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
| US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
| AU2007249399A1 (en) | 2006-05-09 | 2007-11-22 | Braincells, Inc. | Neurogenesis by modulating angiotensin |
| AU2007249435A1 (en) * | 2006-05-09 | 2007-11-22 | Braincells, Inc. | 5 HT receptor mediated neurogenesis |
| BRPI0716604A2 (pt) * | 2006-09-08 | 2013-04-09 | Braincells Inc | combinaÇÕes contendo um derivado de 4-acilaminopiridina |
| EP2066355A2 (en) * | 2006-09-19 | 2009-06-10 | Braincells, Inc. | Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis |
| US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
| US20100184769A1 (en) * | 2007-06-13 | 2010-07-22 | Bayer Schering Pharma Aktiengesellschaft | Pde inhibitors for the treatment of hearing impairment |
| US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
| WO2013106547A1 (en) | 2012-01-10 | 2013-07-18 | President And Fellows Of Harvard College | Beta-cell replication promoting compounds and methods of their use |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE791025A (fr) * | 1971-11-19 | 1973-05-07 | Allen & Hanburys Ltd | Composes heterocycliques |
-
1973
- 1973-01-04 GB GB55373*[A patent/GB1457873A/en not_active Expired
- 1973-12-18 FI FI3900/73A patent/FI57260C/fi active
- 1973-12-18 NO NO4843/73A patent/NO140301C/no unknown
- 1973-12-18 ZA ZA739534A patent/ZA739534B/xx unknown
- 1973-12-19 AU AU63774/73A patent/AU474078B2/en not_active Expired
- 1973-12-20 IL IL43872A patent/IL43872A/xx unknown
- 1973-12-21 DE DE2364076A patent/DE2364076A1/de not_active Withdrawn
- 1973-12-26 US US05/427,558 patent/US3941785A/en not_active Expired - Lifetime
- 1973-12-28 FR FR7346979A patent/FR2213058B1/fr not_active Expired
- 1973-12-28 CA CA189,199A patent/CA1005057A/en not_active Expired
- 1973-12-31 JP JP49004782A patent/JPS4995994A/ja active Pending
- 1973-12-31 IE IE2345/73A patent/IE38681B1/xx unknown
-
1974
- 1974-01-02 CH CH9274A patent/CH618170A5/de not_active IP Right Cessation
- 1974-01-02 AT AT2374A patent/AT336029B/de not_active IP Right Cessation
- 1974-01-02 LU LU69099A patent/LU69099A1/xx unknown
- 1974-01-03 BE BE139496A patent/BE809369A/xx unknown
- 1974-01-03 ES ES422001A patent/ES422001A1/es not_active Expired
- 1974-01-03 SE SE7400062A patent/SE408179B/xx unknown
- 1974-01-04 NL NL7400095A patent/NL7400095A/xx not_active Application Discontinuation
-
1979
- 1979-10-10 FI FI793137A patent/FI793137A7/fi not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO140301C (no) | 1979-08-08 |
| ZA739534B (en) | 1974-11-27 |
| DE2364076A1 (de) | 1974-07-18 |
| AU6377473A (en) | 1975-06-19 |
| FR2213058B1 (cg-RX-API-DMAC7.html) | 1977-07-01 |
| FI793137A7 (fi) | 1981-01-01 |
| NL7400095A (cg-RX-API-DMAC7.html) | 1974-07-08 |
| FI57260B (fi) | 1980-03-31 |
| AT336029B (de) | 1977-04-12 |
| BE809369A (fr) | 1974-07-03 |
| US3941785A (en) | 1976-03-02 |
| IL43872A (en) | 1979-01-31 |
| LU69099A1 (cg-RX-API-DMAC7.html) | 1974-04-02 |
| IL43872A0 (en) | 1974-03-14 |
| FI57260C (fi) | 1980-07-10 |
| ES422001A1 (es) | 1976-08-01 |
| GB1457873A (en) | 1976-12-08 |
| AU474078B2 (en) | 1976-07-15 |
| JPS4995994A (cg-RX-API-DMAC7.html) | 1974-09-11 |
| IE38681B1 (en) | 1978-05-10 |
| ATA2374A (de) | 1976-08-15 |
| CH618170A5 (cg-RX-API-DMAC7.html) | 1980-07-15 |
| NO140301B (no) | 1979-04-30 |
| CA1005057A (en) | 1977-02-08 |
| IE38681L (en) | 1974-07-04 |
| FR2213058A1 (cg-RX-API-DMAC7.html) | 1974-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE408179B (sv) | Analogiforfarande for framstellning av imidazo(5,1-a)-as-triaziner | |
| SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
| SE390819B (sv) | Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat | |
| SE7710600L (sv) | Forfarande for framstellning av 1,3-bensoxazoler | |
| SE411212B (sv) | Forfarande for framstellning av 3-halogen-cefalosporiner | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| SE417601B (sv) | Forfarande for framstellning av amidinokarbamider | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| DK133051C (da) | Analogifremgangsmade til fremstilling af 1,3-oxygenerede 8alfa-ostratriener | |
| NO843825L (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin | |
| DK132707C (da) | Analogifremgangsmade til fremstilling af 1,3,16,17-tetraoxygenerede 8alfa-ostratriener | |
| SE409716B (sv) | Analogiforfarande for framstellning av 11beta-alkyl-delta4-estrener | |
| SE408552B (sv) | Analogiforfarande for framstellning av nya pyrazoloner-(5) | |
| SE426242B (sv) | Analogiforfarande for framstellning av 1,4-bensodiazepinderivat | |
| SE431451B (sv) | Forfarande for framstellning av 2,3-dihydroxipropoxikinoliner eller -isokinoliner | |
| SE421693B (sv) | Forfarande for framstellning av n-substituerade 1-amino-3-fenoxi-propanoler-(2) | |
| SE428015B (sv) | Forfarande for framstellning av 3.4-dihydrokarbostyrilderivat | |
| SE398501B (sv) | Analogiforfarande for framstellning av 1,4-bensodiazepinderivat | |
| SE420603B (sv) | Forfarande for framstellning av metyl-3-(2-kinoxolinylmetylen)-karbazat-n?721, n?724-dioxid | |
| SE388611B (sv) | Analogiforfarande for framstellning av 1,4-bensodiazeponderivat | |
| NO139125C (no) | Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| SE411211B (sv) | Forfarande for framstellning av 3-halogencefalosporiner | |
| SE398122B (sv) | Analogiforfarande for framstellning av pyrazino/1,2-a/indol-2-karboxamidiner | |
| SE7700792L (sv) | Forfarande for framstellning av n,n'-diklor-isoftalsyraamid |